Slow uptake for promising new COVID-19 treatment in Minnesota
Copy shortlink: More than a month after shipments of a promising new COVID-19 treatment started arriving in Minnesota, most of the doses haven't been used even though doctors initially feared demand would far outstrip supply. State health officials say some medical centers have reported a surprising lack of patient interest in the outpatient antibody therapy, which might help people avoid hospitalization, but requires an hourlong infusion. Health systems also have struggled to create a process for providing the treatment, since resources have been stretched thin as the...